New date Dutch Life Sciences conference!

April 19, 2022

Finally we are able to inform you about the definite date for the postponed 2021 edition of the Dutch Life Sciences conference. Please mark May 24, 2022 in your agenda!

Expert Class Financing young Life Sciences companies

April 18, 2022

In this Expert Class financing options and successful strategies for young Life Sciences & Medtech companies are being discussed. The focus is on financing options for biotech and MedTech companies till series A financing round.

Expert Class Life Sciences business- and sales development

February 16, 2022

A solid business development strategy is crucial for the development of life sciences products and companies. For young companies it provides funding for research and product development whereas for larger companies it manage their (IP) portfolios, adjusting risks, revenue streams and company strategy.

Update DLS conference 2021 edition

January 27, 2022

We all looked very much forward to organise the 2021 edition of the Dutch Life Sciences conference early 2022.

Unfortunately due to the latest announced measures by the Dutch Government to prevent the spread of COVID-19 -1,5 meters distance, ⅓ use of the venue capacity and fixed seats-, it is not possible for our production to organise our event.

NEW DATE: Expert Class Governance structure

January 16, 2022

Corporate governance structure for start-ups should identify roles, authority, and timing in key business decisions between shareholders, directors, and the CEO. But if there is a lack of governance structure across the business it could have a negative impact on the success of the company. For instance it could be much harder to attract funding from investors.

2021 CONFERENCE POSTPONED

November 14, 2021

We all looked very much forward to the upcoming Dutch Life Sciences conference on November 25th.

Unfortunately we have to inform you that due to the Dutch Government rules to prevent the spread of COVID-19, it is currently not possible to continue our event on the scheduled date.

Expert Class Stakeholder management

October 15, 2021

Changes to the healthcare systems over the last few years have made market access, pricing and reimbursement critical in driving prescriptions and ultimately sales revenue. In addition to structural changes in the healthcare systems, the dynamics of patients, healthcare policy makers and payer behaviour have altered significantly. The environment is becoming more complex, with a significant shift in the relative importance and roles of key stakeholder groups.